Oxidative DNA damage induced by a hydroperoxide derivative of cyclophosphamide

Free Radical Biology and Medicine

Volumn 37, Issue 6, 2004, Pages 793-802

  Murata, Mariko ^a   Suzuki, Toshinari ^a   Midorikawa, Kaoru ^a   Oikawa, Shinji ^a   Kawanishi, Shosuke ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

4 Hydroperoxycyclophosphamide; Apoptosis; CP; Cyclophosphamide; cyclophosphamide; diethylenetriamine N,N,N ,N ,N pentaacetic acid; DTPA; Fapy; formamidopyrimidine; Fpg; Free radicals; Hydrogen peroxide; Oxidative DNA damage

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; 8 HYDROXYDEOXYGUANOSINE; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CATALASE; CYCLOPHOSPHAMIDE DERIVATIVE; HYDROGEN PEROXIDE; POTASSIUM IODIDE; SCOPOLETIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER; CONTROLLED STUDY; DNA CROSS LINKING; DNA DAMAGE; HUMAN; HUMAN CELL; LEUKEMIA CELL; OXIDATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; CATTLE; COPPER; CROSS-LINKING REAGENTS; CYCLOPHOSPHAMIDE; DEOXYGUANOSINE; DNA; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; EDETIC ACID; FREE RADICALS; HL-60 CELLS; HUMANS; HYDROGEN PEROXIDE; MODELS, CHEMICAL; NAD; OXIDATIVE STRESS; OXYGEN; THYMUS GLAND; TUMOR SUPPRESSOR PROTEIN P53;

EID: 4043064242     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2004.05.009     Document Type: Article

References (47)

1. Jones R.J. Purging with 4-hydroperoxycyclophosphamide. J. Hematother. 1:1992;343-348
2. Takamizawa A., Matsumoto S., Iwata T., Katagiri K., Tochino Y., Yamaguchi K. Preparation of an active species of cyclophosphamide and some related compounds. J. Am. Chem. Soc. 95:1973;985-986
3. Surya Y.A., Rosenfeld J.M., Hillcoat B.L. Cross-linking of DNA in L1210 cells and nuclei treated with cyclophosphamide and phosphoramide mustard. Cancer Treat. Rep. 62:1978;23-29
4. Erickson L.C., Ramonas L.M., Zaharko D.S., Kohn K.W. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro. Cancer Res. 40:1980;4216-4220
5. Kawabata T.T., Chapman M.Y., Kim D.H., Stevens W.D., Holsapple M.P. Mechanisms of in vitro immunosuppression by hepatocyte-generated cyclophosphamide metabolites and 4-hydroperoxycyclophosphamide. Biochem. Pharmacol. 40:1990;927-935
6. Little S.A., Mirkes P.E. DNA cross-linking and single-strand breaks induced by teratogenic concentrations of 4-hydroperoxycyclophosphamide and phosphoramide mustard in postimplantation rat embryos. Cancer Res. 47:1987;5421-5426
7. Fleer R., Ruhland A., Brendel M. The cytotoxic action of activated and non-activated cyclophosphamide in yeast: comparison of induced DNA damage. Chem.-Biol. Interact. 42:1982;67-78
8. Fleer R., Brendel M. Toxicity, interstrand cross-links and DNA fragmentation induced by 'activated' cyclophosphamide in yeast: comparative studies on 4-hydroperoxy-cyclophosphamide, its monofunctional analog, acrolein, phosphoramide mustard, and nor-nitrogen mustard. Chem.-Biol. Interact. 39:1982;1-15
9. Millar B.C., Tilby M.J., Ormerod M.G., Payne A.W., Jinks S., Loverock P.S. Comparative studies of total cross-linking, cell survival and cell cycle perturbations in Chinese hamster cells treated with alkylating agents in vitro. Biochem. Pharmacol. 35:1986;1163-1169
10. Hengstler J.G., Hengest A., Fuchs J., Tanner B., Pohl J., Oesch F. Induction of DNA crosslinks and DNA strand lesions by cyclophosphamide after activation by cytochrome P450 2B1. Mutat. Res. 373:1997;215-223
11. Kubota T., Hanatani Y., Tsuyuki K., Nakada M., Ishibiki K., Abe O., Kamataki T., Kato R. Antitumor effect and metabolic activation of cyclophosphamide and 4-hydroperoxycyclophosphamide in the human breast carcinoma (MX-1)-nude mouse system. Gann. 74:1983;437-444
12. Dizdaroglu M. Substrate specificities and excision kinetics of DNA glycosylases involved in base-excision repair of oxidative DNA damage. Mutat. Res. 531:2003;109-126
13. Cadet J., Douki T., Frelon S., Sauvaigo S., Pouget J.P., Ravanat J.L. Assessment of oxidative base damage to isolated and cellular DNA by HPLC-MS/MS measurement. Free Radic. Biol. Med. 33:2002;441-449
14. Kasugai I., Yamada M. High production of catalase in hydrogen peroxide-resistant human leukemia HL-60 cell lines. Leuk. Res. 16:1992;173-179
15. Ito K., Inoue S., Yamamoto K., Kawanishi S. 8-Hydroxydeoxyguanosine formation at the 5′ site of 5′-GG-3′ sequences in double-stranded DNA by UV radiation with riboflavin. J. Biol. Chem. 268:1993;13221-13227
16. Murata M., Moriya K., Inoue S., Kawanishi S. Oxidative damage to cellular and isolated DNA by metabolites of a fungicide ortho-phenylphenol. Carcinogenesis. 20:1999;851-857
17. Chumakov, P. EMBL Data Library, Accession No. X54156; 1990.
18. Yamashita N., Murata M., Inoue S., Hiraku Y., Yoshinaga T., Kawanishi S. Superoxide formation and DNA damage induced by a fragrant furanone in the presence of copper(II). Mutat. Res. 39:1998;191-201
19. Capon D.J., Chen E.Y., Levinson A.D., Seeburg P.H., Goeddel D.V. Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue. Nature. 302:1983;33-37
20. Yamamoto K., Kawanishi S. Hydroxyl free radical is not the main active species in site-specific DNA damage induced by copper(II) ion and hydrogen peroxide. J. Biol. Chem. 264:1989;15435-15440
21. Maxam A.M., Gilbert W. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 65:1980;499-560
22. Starkebaum G., Harlan J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77:1986;1370-1376
23. El-Saadani M., Esterbauer H., el-Sayed M., Goher M., Nassar A.Y., Jurgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid Res. 30:1989;627-630
24. Arends M.J., Morris R.G., Wyllie A.H. Apoptosis: the role of the endonuclease. Am. J. Pathol. 136:1990;593-608
25. David-Cordonnier M.H., Laval J., O'Neill P. Clustered DNA damage, influence on damage excision by XRS5 nuclear extracts and Escherichia coli Nth and Fpg proteins. J. Biol. Chem. 275:2000;11865-11873
26. Gasparutto D., Ravanat J.L., Gérot O., Cadet J. Characterization and chemical stability of photooxidized oligonucleotides that contain 2,2-diamino-4-[(2-deoxy-β-D-erythro-pentofuranosy)amino]-5(2H)-oxazolone. J. Am. Chem. Soc. 120:1998;10283-10286
27. Tudek B., Van Zeeland A.A., Kusmierek J.T., Laval J. Activity of Escherichia coli DNA-glycosylases on DNA damaged by methylating and ethylating agents and influence of 3-substituted adenine derivatives. Mutat. Res. 407:1998;169-176
28. Denissenko M.F., Pao A., Tang M., Pfeifer G.P. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science. 274:1996;430-432
29. Hollstein M., Sidransky D., Vogelstein B., Harris C.C. p53 mutations in human cancers. Science. 253:1991;49-53
30. Tada-Oikawa S., Oikawa S., Kawanishi S. Role of ultraviolet A-induced oxidative DNA damage in apoptosis via loss of mitochondrial membrane potential and caspase-3 activation. Biochem. Biophys. Res. Commun. 247:1998;693-696
31. Hiraku Y., Sugimoto J., Yamaguchi T., Kawanishi S. Oxidative DNA damage induced by aminoacetone, an amino acid metabolite. Arch. Biochem. Biophys. 365:1999;62-70
32. Oikawa S., Hirosawa I., Hirakawa K., Kawanishi S. Site specificity and mechanism of oxidative DNA damage induced by carcinogenic catechol. Carcinogenesis. 22:2001;1239-1245
33. Zhou D., Lu Y., Steiner M.S., Dalton J.T. Cytochrome P-450 2C9 sensitizes human prostate tumor cells to cyclophosphamide via a bystander effect. Antimicrob. Agents Chemother. 44:2000;2659-2663
34. Xie H.J., Lundgren S., Broberg U., Finnstrom N., Rane A., Hassan M. Effect of cyclophosphamide on gene expression of cytochromes p450 and beta-actin in the HL-60 cell line. Eur. J. Pharmacol. 449:2002;197-205
35. Pryor W.A., Tang R.H. Ethylene formation from methional. Biochem. Biophys. Res. Commun. 81:1978;498-503
36. Borch R.F., Getman K.M. Base-catalyzed hydrolysis of 4- hydroperoxycyclophosphamide: evidence for iminocyclophosphamide as an intermediate. J. Med. Chem. 27:1984;485-490
37. Oikawa S., Kawanishi S. Distinct mechanisms of site-specific DNA damage induced by endogenous reductants in the presence of iron(III) and copper(II). Biochim. Biophys. Acta. 1399:1998;19-30
38. Oikawa S., Kawanishi S. Site-specific DNA damage induced by NADH in the presence of copper(II): role of active oxygen species. Biochemistry. 35:1996;4584-4590
39. Blair D., Diehl H. Bathophenanthrolinedisulphonic acid and bathocuproinedisulphonic acid, water soluble reagents for iron and copper. Talanta. 7:1961;163-174
40. Morgenstern S., Flor R., Kessler G., Klein B. Automated determination of NAD-coupled enzymes: determination of lactic dehydrogenase. Anal. Biochem. 13:1965;149-161
41. Theophanides T., Anastassopoulou J. Copper and carcinogenesis. Crit. Rev. Oncol. Hematol. 42:2002;57-64
42. Land E.J., Swallow A.J. One-electron reactions in biochemical systems as studied by pulse radiolysis. IV. Oxidation of dihydronicotinamide-adenine dinucleotide. Biochim. Biophys. Acta. 234:1971;34-42
43. Kukielka E., Cederbaum A.I. Ferritin stimulation of hydroxyl radical production by rat liver nuclei. Arch. Biochem. Biophys. 308:1994;70-77
44. Malaisse W.J., Hutton J.C., Kawazu S., Herchulz A., Valverde I., Sener A. The stimulus-secretion coupling of glucose-induced insulin release. XXXV. The links between metabolic and cationic events. Diabetologia. 16:1979;331-341
45. Chetsanga C.J., Polidori G., Mainwaring M. Analysis and excision of ring-opened phosphoramide mustard-deoxyguanine adducts in DNA. Cancer Res. 42:1982;2616-2621
46. Maccubbin A.E., Caballes L., Riordan J.M., Huang D.H., Gurtoo H.L. A cyclophosphamide/DNA phosphoester adduct formed in vitro and in vivo. Cancer Res. 51:1991;886-892
47. Zhong R.K., Donnenberg A.D., Rubin J., Ball E.D. Differential effect of 4-hydroperoxycyclophosphamide and antimyeloid monoclonal antibodies on T and natural killer cells during bone marrow purging. Blood. 83:1994;2345-2351